JP2025503910A5 - - Google Patents
Info
- Publication number
- JP2025503910A5 JP2025503910A5 JP2024543337A JP2024543337A JP2025503910A5 JP 2025503910 A5 JP2025503910 A5 JP 2025503910A5 JP 2024543337 A JP2024543337 A JP 2024543337A JP 2024543337 A JP2024543337 A JP 2024543337A JP 2025503910 A5 JP2025503910 A5 JP 2025503910A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- disease
- combination according
- disorder
- cns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303673P | 2022-01-27 | 2022-01-27 | |
| US63/303,673 | 2022-01-27 | ||
| US202263321335P | 2022-03-18 | 2022-03-18 | |
| US63/321,335 | 2022-03-18 | ||
| PCT/US2023/011746 WO2023147058A2 (en) | 2022-01-27 | 2023-01-27 | Compositions for treating neurological disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503910A JP2025503910A (ja) | 2025-02-06 |
| JP2025503910A5 true JP2025503910A5 (https=) | 2026-01-19 |
Family
ID=87472585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543337A Pending JP2025503910A (ja) | 2022-01-27 | 2023-01-27 | 神経疾患を処置するための組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250109398A1 (https=) |
| EP (1) | EP4469156A4 (https=) |
| JP (1) | JP2025503910A (https=) |
| CN (1) | CN119677545A (https=) |
| AU (1) | AU2023211606A1 (https=) |
| CA (1) | CA3248890A1 (https=) |
| WO (1) | WO2023147058A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118599984B (zh) * | 2024-04-22 | 2025-12-09 | 暨南大学附属第一医院（广州华侨医院） | Chchd2在制备促进神经干细胞增殖与分化产品中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20190992T1 (hr) * | 2014-12-24 | 2019-09-20 | Uniqure Ip B.V. | Suprimiranje gena za huntingtin inducirano s rnai |
| JP2018500037A (ja) * | 2014-12-31 | 2018-01-11 | シンセティック ジェノミクス インコーポレーテッド | 高効率なインビボゲノム編集のための組成物及び方法 |
| KR102427379B1 (ko) * | 2016-05-18 | 2022-08-02 | 보이저 테라퓨틱스, 인크. | 헌팅톤 질환을 치료하기 위한 조성물 및 방법 |
| US10457940B2 (en) * | 2016-09-22 | 2019-10-29 | University Of Massachusetts | AAV treatment of Huntington's disease |
| SG11202000840YA (en) * | 2017-07-31 | 2020-02-27 | Reflection Biotechnologies Ltd | Cellular models of and therapies for ocular diseases |
| US11364309B2 (en) * | 2017-11-10 | 2022-06-21 | Norwegian University Of Science And Technology (Ntnu) | Neuronal enhancers |
| AU2019382824A1 (en) * | 2018-11-19 | 2021-06-03 | Uniqure Ip B.V. | Method and means to deliver miRNA to target cells |
| CN115443339A (zh) * | 2019-12-20 | 2022-12-06 | 阿斯克肋匹奥生物制药公司 | 用于治疗亨廷顿病的方法 |
| GB202005732D0 (en) * | 2020-04-20 | 2020-06-03 | Synpromics Ltd | Regulatory nucleic acid sequences |
| EP4213891A4 (en) * | 2020-09-21 | 2025-07-23 | Askbio Inc | METHODS OF TREATING NEUROLOGICAL DISEASE |
-
2023
- 2023-01-27 JP JP2024543337A patent/JP2025503910A/ja active Pending
- 2023-01-27 US US18/833,081 patent/US20250109398A1/en active Pending
- 2023-01-27 WO PCT/US2023/011746 patent/WO2023147058A2/en not_active Ceased
- 2023-01-27 AU AU2023211606A patent/AU2023211606A1/en active Pending
- 2023-01-27 EP EP23747653.6A patent/EP4469156A4/en active Pending
- 2023-01-27 CN CN202380031445.3A patent/CN119677545A/zh active Pending
- 2023-01-27 CA CA3248890A patent/CA3248890A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4206216B1 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| KR20240113624A (ko) | Aav 캡시드 변이체 및 이의 용도 | |
| JP2023542211A5 (https=) | ||
| EP4476241A1 (en) | Aav capsid variants and uses thereof | |
| JP2022535749A5 (https=) | ||
| CN113557243A (zh) | 用于神经变性疾病的基因疗法 | |
| JP2025507958A (ja) | 操作された核内低分子ＲＮＡ（ｓｎＲＮＡ）を含む組成物および方法 | |
| JP2023537980A5 (https=) | ||
| KR20250102136A (ko) | 중추 신경계에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법 | |
| US20260092291A1 (en) | Novel dual helper plasmid | |
| KR20260016939A (ko) | 아데노 부속 바이러스 캡시드 단백질, 이를 포함하는 아데노 부속 바이러스, 벡터 및 응용 | |
| WO2025038430A1 (en) | Aav capsid variants and uses thereof | |
| JP2025503910A5 (https=) | ||
| JP2024515902A5 (https=) | ||
| JP2023507741A5 (https=) | ||
| CA3219287C (en) | Dual helper plasmid | |
| KR102814185B1 (ko) | 라포라병을 예방 또는 치료하기 위한 재조합 아데노 연관 바이러스 및 이를 포함하는 약학적 조성물 | |
| US10105450B2 (en) | Promoter compositions | |
| US12305188B2 (en) | Dual helper plasmid | |
| EP4534097A1 (en) | Composition for treating retinal or macular diseases | |
| WO2025160429A1 (en) | Artificial micrornas targeting snca | |
| KR20260046127A (ko) | 뇌 지향성 aav 변이체 | |
| KR20250080845A (ko) | 라포라병을 예방 또는 치료하기 위한 재조합 아데노 연관 바이러스 및 이를 포함하는 약학적 조성물 | |
| TW202548014A (zh) | 靶向亨丁頓舞蹈症之人工ｍｉｃｒｏｒｎａ | |
| CN116670160A (zh) | Dlx2载体 |